Angiogenic gene therapy for experimental critical limb ischemia: Acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2

Circulation Research

Volumn 90, Issue 9, 2002, Pages 966-973

  Masaki, Ichiro ^a   Yonemitsu, Yoshikazu ^a   Yamashita, Akihisa ^a   Sata, Shihoko ^a   Tanii, Mitsugu ^a   Komori, Kimihiro ^a   Nakagawa, Kazunori ^a   Hou, Xiaogang ^a   Nagai, Yoshiyuki ^a   Hasegawa, Mamoru ^a   Sugimachi, Keizo ^a   Sueishi, Katsuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Fibroblast growth factor 2; Limb ischemia; Limb salvage; Vascular endothelial growth factor

Indexed keywords

ACTIN; FIBROBLAST GROWTH FACTOR 2; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 165; VASCULOTROPIN ANTIBODY;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE OVEREXPRESSION; GENE THERAPY; GENE TRANSFER; LIMB AMPUTATION; LIMB ISCHEMIA; LIMB SALVAGE; MALE; MOUSE; NONHUMAN; PERFUSION; PRIORITY JOURNAL; SKELETAL MUSCLE; SMOOTH MUSCLE FIBER; TREATMENT PLANNING;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; BLOOD VESSELS; DISEASE MODELS, ANIMAL; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC VECTORS; HINDLIMB; HUMANS; ISCHEMIA; LYMPHOKINES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, NUDE; MUSCLES; PROGNOSIS; REGENERATION; SENDAI VIRUS; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037123968     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000019540.41697.60     Document Type: Article

References (24)

1. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
2. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: Preliminary clinical results
3. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1
4. Angiopoietin-1 protects the adult vasculature against plasma leakage
5. VEGF gene therapy: Stimulating angiogenesis or angiomagenesis?
6. Characterization of in vivo gene transfer into the arterial wall mediated by the Sendai virus (HVJ)-liposomes: An effective tool for the in vivo study of arterial diseases
7. VEGF gene delivery to myocardium: Deleterious effects of unregulated expression
8. Effects of acidic fibroblast growth factor on normal and ischemic myocardium
9. Angiogenesis therapy: Amidst the hype, the neglected potential for serious side effects
10. Efficient gene transfer to the airway epithelium using recombinant Sendai virus
11. Recombinant Sendai virus-mediated gene transfer to vasculature: A new class of efficient gene transfer vector to the vascular system
12. Creation of an infectious recombinant Sendai virus expressing the firefly luciferase gene from the 3′ proximal first locus
13. Recovery of mitogenic activity of a growth factor mutant with a nuclear translocation sequence
14. Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo
15. Mouse model of angiogenesis
16. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization
17. Fibroblast growth factor-2 induces vascular endothelial growth factor expression in the endothelial cells of forming capillaries: An autocrine mechanism contributing to angiogenesis
18. Abnormal blood vessel development and lethality in embryos lacking a single vascular endothelial growth factor allele
19. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor
20. VEGF gene delivery to muscle: Potential role for vasculogenesis in adults
21. Angiogenic and inflammatory responses following skeletal muscle injury are altered by immune neutralization of endogenous basic fibroblast growth factor, insulin-like growth factor-1 and transforming growth factor-β1
22. Basic fibroblast growth factor promotes in vivo muscle regeneration in murine muscular dystrophy
23. Tubulin: A factor necessary for the synthesis of both Sendai virus and vesicular stomatitis virus RNAs
24. Involvement of a cellular glycolytic enzyme, phosphoglycerate kinase, in Sendai virus transcription